4-(8-bromodibenz[b,f]oxepin-10-yl)-1,2,3,6-tetrahydro-1-methylpyridine and 4-(2-bromodibenzo[a,d]cyclophetatriene-11-yl)-1,2,3,6-tetrahydro-1-methy lpyridine for dermal inflammation
US4595689A · kind A · utility
1Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 1984 |
| Grant date | Jun 17, 1986 |
| Priority date | — |
| Expiry date | Feb 9, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/70
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A method of treating inflammation which comprises topically administering to the affected area a compound of the formula ##STR1## or a pharmaceutically acceptable addition salt thereof, is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.